Leisure Capital Management Agenus Inc Transaction History

Leisure Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$1.12 - $1.88 $1,906 - $3,199	-1,702 Reduced 13.86%	10,577 $11,000
Q2 2023 Jul 27, 2023	SELL	$1.31 - $2.04 $755 - $1,177	-577 Reduced 4.49%	12,279 $19,000
Q3 2022 Nov 01, 2022	BUY	$1.96 - $3.14 $25,197 - $40,367	12,856 New	12,856 $26,000
Q2 2022 Jul 27, 2022	SELL	$1.3 - $2.64 $20,463 - $41,556	-15,741 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.35 - $3.47 $51 - $76	-22 Reduced 0.14%	15,741 $39,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $12,958 - $25,474	4,438 Added 39.19%	15,763 $51,000
Q3 2021 Nov 03, 2021	SELL	$4.98 - $6.63 $15,562 - $20,718	-3,125 Reduced 21.63%	11,325 $59,000
Q2 2021 Aug 06, 2021	BUY	$2.56 - $5.49 $36,992 - $79,330	14,450 New	14,450 $79,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Leisure Capital Management, based on Form 13F filings with the SEC.

Stay updated on Leisure Capital Management with notifications on news.